Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

BETAMETHASONE DIPROPIONATE

BETAMETHASONE DIPROPIONATE

Standard Dose
EQ 0.05% BASE/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview BETAMETHASONE DIPROPIONATE is listed in Drugs@FDA under application 211722 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BETAMETHASONE DIPROPIONATE Form and strength SPRAY;TOPICAL - EQ 0.05% BASE/SPRAY Sponsor SUN PHARMA CANADA Submission history Latest submission status date: 2020-06-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview BETAMETHASONE DIPROPIONATE is listed in Drugs@FDA under application 211722 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BETAMETHASONE DIPROPIONATE Form and strength SPRAY;TOPICAL - EQ 0.05% BASE/SPRAY Sponsor SUN PHARMA CANADA Submission history Latest submission status date: 2020-06-17 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.